Latest Financial Results

Investor Relations

Aug 11, 2022 • 4:05 PM EDT

Q2 2022 Quarterly Results

Quarter Ended Jun 30, 2022

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2021

Stock Snapshot

Company Overview

Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.

IR Contacts

Company

Achieve Life Sciences, Inc.
22722 29th Dr. SE
Suite 100
Bothell, WA 98021
United States
T: 425-686-1500

Investor Relations

Scope Investor Relations
Jonathan Wexler
T: 203-247-8767
jonathan@scopeir.com